Effect of ondansetron for preventing of ovarian hyperstimulation syndrome: in an experimental rat model
Objective: Ovarian hyperstimulation syndrome is an iatrogenic condition that occurs in the treatment of infertility. There is no specific treatment available for OHSS. Cabergoline is a dopamine receptor 2 agonist and VEGF-VEGF2 receptor antagonist . Recently, cabergoline has been widely used to prev...
Saved in:
| Main Authors: | Şükrü Bakırcı, Nevin Sağsöz, Tuba Devrim, Yaşar Şahin, Murat Bulanık, Hilal Gözüyukarı |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | Gynecological Endocrinology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09513590.2022.2163233 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative study of cabergoline and hydroxychloroquine to prevent ovarian hyperstimulation syndrome (OHSS) in PCOS patients: a pilot randomized clinical trial
by: Elnaz Salari, et al.
Published: (2025-05-01) -
Investigating the effect of ondansetron in reducing myoclonic movements caused by intravenous administration of etomidate
by: Mohammad Alipour, et al.
Published: (2025-04-01) -
A study comparing the effectiveness of ondansetron versus ondansetron combined with dexamethasone for preventing postoperative nausea and vomiting in laparoscopic surgeries
by: Rajan B. Pandya, et al.
Published: (2024-04-01) -
Outcome of ondansetron on subarachnoid block-induced hypotension in infraumbilical surgeries
by: Renganathan S, et al.
Published: (2025-05-01) -
The effect of high-fat diet on the pharmacokinetics of ondansetron hydrochloride tablets in healthy Chinese subjects
by: Na Zhao, et al.
Published: (2025-03-01)